By Joanna Carver
(June 11, 2018) -- A new study by Waldemar Gorski, professor and chair of the UTSA Department of Chemistry, and Stanton McHardy, associate professor of research in chemistry and director of theUTSA Center
The most common method of testing for infection in medical facilities is a strip that turns a certain color when infected fluids come into contact with it.
“The problem with this method is that it’s imprecise,” Gorski said. “The human eye is forced to judge the level of infection based on the hue and deepness of a color. It’s difficult to make an accurate call based on that.” Furthermore, roughly a third of samples cannot be tested because the fluids contain blood or are too opaque.
Other methods include microbiology or examining body fluid samples under a microscope and counting white blood cells, also known as leukocytes, which are an indicator of an infection. However, these can be slow processes and require more highly trained personnel.
Gorski, seeing a need for an easier and more rapid method of testing for infection, resolved to test an electrochemical approach, and sought out McHardy, a medicinal chemist. Together, they created molecules that bind to leukocyte enzymes and produce an electrical current to signal the presence of an infection.
Their new molecules are housed on a testing strip. After being contacted with infected bodily fluids, the strip is connected to a computer monitor that displays a clear range of electrochemical responses demonstrating the severity of an infection.
“The signs and symptoms people demonstrate aren’t always reflective of the level of the infection they have,” McHardy said. “This method could very easily show just how serious an infection is and make diagnosis a much quicker process, possibly preventing a more serious illness.”
Gorski believes the method could be especially useful to people who have just undergone surgery, as it could determine definitively whether they have an infection from the procedure before it worsens.
To date, Gorski and McHardy have filed a patent for their invention, published two papers and plan to work with an engineer in the future to streamline its design.
(June 11, 2018) -- A new study by Waldemar Gorski, professor and chair of the UTSA Department of Chemistry, and Stanton McHardy, associate professor of research in chemistry and director of the
The most common method of testing for infection in medical facilities is a strip that turns a certain color when infected fluids come into contact with it.
“The problem with this method is that it’s imprecise,” Gorski said. “The human eye is forced to judge the level of infection based on the hue and deepness of a color. It’s difficult to make an accurate call based on that.” Furthermore, roughly a third of samples cannot be tested because the fluids contain blood or are too opaque.
Other methods include microbiology or examining body fluid samples under a microscope and counting white blood cells, also known as leukocytes, which are an indicator of an infection. However, these can be slow processes and require more highly trained personnel.
Gorski, seeing a need for an easier and more rapid method of testing for infection, resolved to test an electrochemical approach, and sought out McHardy, a medicinal chemist. Together, they created molecules that bind to leukocyte enzymes and produce an electrical current to signal the presence of an infection.
Their new molecules are housed on a testing strip. After being contacted with infected bodily fluids, the strip is connected to a computer monitor that displays a clear range of electrochemical responses demonstrating the severity of an infection.
“The signs and symptoms people demonstrate aren’t always reflective of the level of the infection they have,” McHardy said. “This method could very easily show just how serious an infection is and make diagnosis a much quicker process, possibly preventing a more serious illness.”
Gorski believes the method could be especially useful to people who have just undergone surgery, as it could determine definitively whether they have an infection from the procedure before it worsens.
To date, Gorski and McHardy have filed a patent for their invention, published two papers and plan to work with an engineer in the future to streamline its design.
No comments:
Post a Comment